Giorgia Guglielmi

Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.

Delivery mode influences the composition of the infant gut microbiota

The findings suggest that delivery mode, rather than birth canal exposure, has a strong influence on the composition of the infant microbiota.

Gut microbes modulate mice’s immune response during infection with malaria parasites

Modulating the gut microbiota could help to increase Plasmodium-specific immunity, thus reducing disease severity and malaria-associated mortality.

Scientists find microbial “signature” of depression

Researches have found that MDD is characterized by disturbances in the gut microbiota and may allow clinicians to better diagnose it.

Two-pronged approach may help to treat inflammatory bowel disease

A two-pronged treatment strategy — consisting of an engineered peptide and an FDA-approved drug —  could help to reduce gut inflammation.

Can gut microbes help to manage nonalcoholic fatty liver disease?

The current knowledge of the gut-liver axis in NAFLD may lead to the development of microbiota-based personalized approaches for managing the condition.

How gut bacteria could help to rebuild the immune system

A study published in Nature suggests new approaches to improve BMTs as well as treatments for immune-mediated diseases by regulating the gut microbiota.

More clues link gut microbes with multiple sclerosis

People with active multiple sclerosis have high levels of particular gut antibodies, called immunoglobulin A (IgA), in the central nervous systems.

Skin microbes produce their own antibiotic to fight off harmful bacteria

Some C. acnes strains harbored genes that encoded a molecule similar in structure to a known antibiotic called berninamycin.

Gut microbes may protect against radiation-induced injury

Researches suggest that Lachnospiraceae and Enterococcaceae, as well as bacterial metabolites such as propionate can contribute to radioprotection.

How harmful bacteria can thrive in the lungs

Changes in one of the P. aeruginosa’s environmental sensing systems allow it to adapt to the environment of the lungs, causing chronic infections.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.